GlassScriptPhysician profile
Maria Grace Berdayes
NPI 1871524348
$12,437.52
in general payments reported to CMS, 2019-2025
67 companies · $1,220 in 2025
The $1,220 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,101 · 2020: $1,693 · 2021: $1,979 · 2022: $2,107 · 2023: $1,904 · 2024: $1,433 · 2025: $1,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,549 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,549.02 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,558.88 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,088.95 | 2019-2025 | Vraylar, Ubrelvy, Linzess |
| Glaxosmithkline, LLC. | $1,086.92 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $755.23 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $741.19 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $480.07 | 2019-2025 | Repatha, Otezla, Repatha |
| Astellas Pharma US INC | $461.95 | 2019-2025 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $411.59 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $368.16 | 2019-2025 | Xifaxan, Trulance |
| Sanofi-Aventis U.S. LLC | $365.50 | 2019-2023 | |
| Tris Pharma INC | $344.40 | 2022-2023 | Dyanavel Xr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $324.40 | 2019-2022 | |
| Amarin Pharma, INC. | $298.33 | 2019-2021 | |
| Pfizer INC. | $284.31 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $244.23 | 2019-2023 | Trintellix |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $242.29 | 2022-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $233.08 | 2020-2023 | Xarelto |
| Allergan, INC. | $212.35 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $210.04 | 2019-2022 | |
| Radius Health, INC. | $203.56 | 2019-2024 | Tymlos |
| Abbott Laboratories | $194.46 | 2021-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $162.17 | 2019-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $161.83 | 2021-2024 | |
| Exact Sciences Corporation | $155.84 | 2023-2025 | Cologuard Collection Kit |
| Eisai INC. | $147.41 | 2020-2025 | |
| Abiomed | $140.42 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $134.37 | 2019-2024 | Zoryve |
| Jazz Pharmaceuticals INC. | $125.09 | 2019-2022 | |
| Vertiflex, INC. | $96.29 | 2019 | |
| Medtronic, INC. | $95.07 | 2021-2025 | Symplicity G3, Inpen Smart Insulin Delivery System |
| Esperion Therapeutics, INC. | $74.52 | 2021-2024 | Nexletol |
| Medtronic Minimed, INC. | $74.19 | 2019-2020 | |
| Inspire Medical Systems, INC. | $64.53 | 2024-2025 | Inspire |
| Axsome Therapeutics, INC. | $55.09 | 2023-2025 | Auvelity |
| Paratek Pharmaceuticals, INC. | $48.46 | 2021-2025 | Nuzyra |
| Lundbeck LLC | $45.29 | 2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $43.95 | 2022-2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $42.07 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $41.43 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $39.41 | 2020 | |
| Phathom Pharmaceuticals, INC. | $38.70 | 2024 | Voquezna |
| Shire North American Group INC | $38.18 | 2019 | |
| Nabriva Therapeutics, Plc | $35.64 | 2021 | |
| Bausch Health US, LLC | $35.31 | 2021 | |
| Corium, LLC | $33.40 | 2022 | |
| Horizon Therapeutics Plc | $29.37 | 2019 | |
| Theratechnologies INC. | $27.62 | 2025 | Egrifta, Trogarzo |
| Insulet Corporation | $27.55 | 2025 | Omnipod |
| Biohaven Pharmaceutical Holding Company LTD. | $27.01 | 2022 | |
| Strongbridge US INC. | $26.49 | 2020 | |
| Optinose US, INC. | $22.66 | 2019 | |
| Genentech USA, INC. | $21.60 | 2021 | |
| Antares Pharma, INC. | $20.59 | 2025 | Xyosted |
| Tandem Diabetes Care, INC. | $20.08 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Xeris Pharmaceuticals, INC. | $19.43 | 2022 | |
| Inari Medical, INC. | $19.10 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amag Pharmaceuticals, INC. | $18.10 | 2019 | |
| Supernus Pharmaceuticals, INC. | $18.04 | 2025 | Qelbree |
| Neos Therapeutics, LP | $15.78 | 2024 | Adzenys Xr-Odt |
| Tolmar, INC. | $15.01 | 2025 | Jatenzo |
| Philips North America LLC | $13.97 | 2023 | |
| Coherus Oncology, INC. | $13.24 | 2023 | |
| Scilex Pharmaceuticals INC. | $12.52 | 2020 | |
| Duchesnay USA Incorporated | $12.15 | 2019 | |
| Adlon Therapeutics L.P. | $11.50 | 2021 | |
| Itamar Medical INC | $7.16 | 2023 | Watchpatone |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Berdayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.